Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06967298 · ClinicalTrials.gov registry record · NA
Total30 For Contact Lens Dropouts
A NA study, sponsored by Southern College of Optometry.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06967298: Completed NA study, sponsored by Southern College of Optometry.
NCT06967298 is a NA study that has completed, run by Southern College of Optometry. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06967298, a NA study, has completed, sponsored by Southern College of Optometry.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Contact lens (CL) discomfort is a complex phenomenon that has been defined by the Tear Film and Ocular Surface Society (TFOS) in their seminal report on CL discomfort as a condition that results in "episodic or persistent adverse ocular sensation related to lens wear, either with or without visual disturbance resulting from reduced compatibility between the CL and the environment, which can lead to decreased wearing time and discontinuation of CL wear."
Primary Outcome
Participants will be refit into new contact lenses and their comfort will be asked about their comfort.In which a higher score is better.
Interventions
- DEVICE T30 Contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-04-23 |
| Est. Completion | 2024-11-28 |
| Phase | NA |
What the finished NCT06967298 record still lists
NCT06967298 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which T30 Contact lenses is the first listed.
NCT06967298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06967298 about?
NCT06967298 is a clinical study titled "Total30 For Contact Lens Dropouts". Contact lens (CL) discomfort is a complex phenomenon that has been defined by the Tear Film and Ocular Surface Society (TFOS) in their seminal report on CL discomfort as a condition that results in "episodic or persistent adverse ocular sensation related to lens wear, either with or without visual d...
What is the current status of trial NCT06967298?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-04-23. Estimated completion is 2024-11-28.
What interventions are being tested in trial NCT06967298?
The interventions under investigation include: T30 Contact lenses (DEVICE).
Who is sponsoring clinical trial NCT06967298?
This trial is sponsored by Southern College of Optometry, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06967298's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI